This review synthesizes current evidence linking microbiota alterations to Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and strokeincluding post-stroke cognitive impairment (PSCI), as well as major depressive disorder (MDD), bipolar disorder (BD), anxiety disorders, post-traumatic stress disorder (PTSD), and chronic fatigue syndrome (CFS)
An 8-week randomized double-blind clinical trial compared GHK-Cu in a nano-lipid carrier against Matrixyl 3000, a popular cosmetic peptide
Current clinical trials show AOD9604 has a good safety profile
Q3: Is it safe for long-term use
Week-by-Week Results: Appetite, Energy, and the Numbers I logged daily hunger scores on a 110 scale (1 = starving, 10 = completely full) right before lunch and dinner, plus my total daily calorie intake